‘High-ranking physicians and executives
at Partners HealthCare, which includes Massachusetts General and
Brigham and Women’s hospitals, can no longer receive stock or
unlimited fees for sitting on the boards of biotechnology and
pharmaceutical companies, under new rules that took effect Friday.
Partners estimates that the policy
affects roughly 25 vice presidents, clinical department heads, and
other top executives who are directors for some of the nation’s
leading drug companies. The rules limit their pay to $500 an hour, or
$5,000 for a typical 10-hour day attending a board meeting; the rules
ban executives and high-level physicians outright from taking company
stock as compensation.’
Book Mark it-> del.icio.us | Reddit | Slashdot | Digg | Facebook | Technorati | Google | StumbleUpon | Window Live | Tailrank | Furl | Netscape | Yahoo | BlinkList